Results for this period
First quarter2025年4月1日〜2025年6月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
ヘルスケア事業の医療関連機器製造装置や自動包装機ラインの売上増加、自動車事業の電動駆動関連設備の大口案件の売上計上。セグメント別では、プラント・エネルギー、エナジーソリューションズ、産業機械の売上減少があった一方、エレクトロニクス、自動車、ヘルスケア、航空・インフラが増加。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年4月1日〜2025年6月30日 |
| Net Sales | ¥49,489 million (YoY +14.1%) |
| Operating profit | ¥2,501 million (YoY +19.2%) |
| Ordinary income | ¥2,488 million (YoY +35.6%) |
| Profit attributable to owners of the parent | ¥1,745 million (YoY +60.9%) |
| Net income per share | 54円74銭 |
| Equity ratio | End of the current fiscal period 48.4 / End of previous period 46.5 |
| Total assets | ¥165,311 million |
| Net assets | ¥80,234 million |
| Cash flows from operating activities | ¥4,905 million |
| Cash flows from investing activities | ¥166 million |
| Cash flows from financing activities | ¥-1,718 million |
| Cash and cash equivalents at end of period | ¥36,763 million |
| Full-year earnings forecast | Net Sales ¥220,000 million (YoY -0.8%) / Operating profit ¥12,000 million (YoY -8.4%) / Ordinary income ¥12,300 million (YoY -9.5%) / Net income ¥8,600 million (YoY -2.7%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥92 → ¥108(+17.4%) |
| Segment revenue | Plant and Energy Business ¥4,301 million (YoY -13.8%), Energy Solutions Business ¥9,219 million (YoY -1.7%), Industrial-Machinery Business ¥5,135 million (YoY -27.3%), Electronics Business ¥11,551 million (YoY +4.9%), Automotive Business ¥11,285 million (YoY +57.8%), Healthcare Business ¥6,543 million (YoY +178.6%), Aerospace and Infrastructure Business ¥1,431 million (YoY +2.6%) |
| Segment profit | Plant and Energy Business ¥140 million (YoY -45.0%), Energy Solutions Business ¥326 million (YoY -23.8%), Industrial-Machinery Business ¥-128 million, Electronics Business ¥640 million (YoY +9.3%), Automotive Business ¥635 million (YoY +196.1%), Healthcare Business ¥658 million, Aerospace and Infrastructure Business ¥73 million (YoY -40.3%) |
| Depreciation and amortization | ¥272 million |
| Breakdown of extraordinary income (loss) | 当期の特別損失合計は「-」で、特別損益の計上なし。前年同期は投資有価証券評価損0百万円。 |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 0 new companies and 0 excluded companies (no significant changes to the scope of consolidation during the period) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (no target participants specified) |
| Issued Shares at Period-End | 32,759,200 Shares |
| Treasury Shares at Period-End | 851,885 Shares |
| Factors Behind Changes in Business Performance | ヘルスケア事業の医療関連機器製造装置や自動包装機ラインの売上増加、自動車事業の電動駆動関連設備の大口案件の売上計上。セグメント別では、プラント・エネルギー、エナジーソリューションズ、産業機械の売上減少があった一方、エレクトロニクス、自動車、ヘルスケア、航空・インフラが増加。 |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ヘルスケア事業の医療関連機器製造装置や自動包装機ラインの売上が大幅に増加したこと、自動車事業で電動駆動関連設備の大口案件を売上計上したことによる。